LNX1 Contributes to Cell Cycle Progression and Cisplatin Resistance.
Jang M, Park R, Park YI, Park Y, Lee JI, Namkoong S, Lee EJ, Park J.
Jang M, et al. Among authors: park yi, park r, park y, park j.
Cancers (Basel). 2021 Aug 12;13(16):4066. doi: 10.3390/cancers13164066.
Cancers (Basel). 2021.
PMID: 34439220
Free PMC article.